Iftekhar Kalsekar

Johnson & Johnson (United States)

Papers

3

Total Citations

203

H-Index

3

About

Iftekhar Kalsekar is a leading researcher in pulmonary medicine and health outcomes, with a focus on advancing the diagnosis and management of lung cancer. His work is particularly influential in the field of interventional pulmonology, where he has made significant contributions to understanding the effectiveness of emerging bronchoscopic technologies. Dr. Kalsekar’s research has been instrumental in evaluating the real-world performance of robot-assisted bronchoscopy, demonstrating its diagnostic utility for small and difficult-to-reach pulmonary nodules in community settings, a critical step for generalizing these advanced techniques beyond academic centers. He has also provided key insights into the methodological challenges of bronchoscopy research, notably through his highly cited work on alternative approaches to calculating diagnostic yield. With a cumulative citation count exceeding 200 across his most prominent papers, his impact is clear. Notably, his 2023 study on recurrence-free survival after surgical resection for non-small cell lung cancer provides a vital benchmark for clinical outcomes, further solidifying his role in shaping evidence-based practices for lung cancer care.

Research Focus

Key Achievements

3
H-Index
3
Papers
203
Total Citations
68
Avg Citations/Paper
🏆 Most Cited Paper
The Impact of Alternative Approaches to Diagnostic Yield Calculation in Studies of Bronchoscopy
104 citations · 2021
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Johnson & Johnson (United States)

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago